Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,982 public trials 1,832 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer.

NCT00432562

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +22 more
Locations: Clinical Investigative Site Buenos Aires, Argentina

Clinical Investigative Site Mendoza, Argentina

Clinical Investigative Site Rosario, Argentina

Clinical Investigative Site San Miguel de Tucumán, Argentina

View Trial Details

Completed

Study of Augmented Hyper-CVAD in Acute Lymphoblastic Leukemia Salvage

NCT00890656

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Cyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab (CFAR) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

NCT01082939

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma

NCT00018954

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +31 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

National Cancer Institute of Egypt Cairo, Egypt

Kidwai Memorial Institute of Oncology Bangalore, India

Cancer Institute (W.I.A.) Madras, India

View Trial Details

Completed

Rituximab Combined With ESHAP in Patients With Relapse or Refractory Diffuse Large B Cell Lymphoma (DLBCL)

NCT00568815

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Fudan University Cancer Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Completed

L-asparaginase Monotherapy as Salvage Treatment in Patients With NK/T Cell Lymphoma

NCT00854425

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Fudan University Cancer Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Blood Samples to Evaluate Biomarkers of Donor Chimerism

NCT00764829

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Multi-dose-escalation Safety and Pharmacokinetic Study of SAR3419 as Single Agent in Relapsed/Refractory B-cell Non Hodgkin's Lymphoma

NCT00549185

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States

View Trial Details

Completed

Effect of Intermittent Pneumatic Compression on Ulcer Healing in Subjects With Secondary Lymphedema

NCT01079299

Conditions: Cardiovascular Diseases, Hemic and Lymphatic Diseases, Leg Ulcer, +8 more
Locations: Calvary Hospital, Center for Curative and Palliative Wound Care The Bronx, New York, United States

View Trial Details

Completed

Study of Forodesine Hydrochloride in Patients With Advanced, Fludarabine-refractory Chronic Lymphocytic Leukemia (CLL)

NCT00289549

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations: MD Anderson Cancer Center, University of Texas Houston, Texas, United States

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions